EXFY vs. DCBO, SCWX, RDVT, VMEO, ECX, CGNT, RCAT, NEXN, WEAV, and SMWB
Should you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Docebo (DCBO), SecureWorks (SCWX), Red Violet (RDVT), Vimeo (VMEO), ECARX (ECX), Cognyte Software (CGNT), Red Cat (RCAT), Nexxen International (NEXN), Weave Communications (WEAV), and Similarweb (SMWB). These companies are all part of the "computer software" industry.
Expensify vs. Its Competitors
Expensify (NASDAQ:EXFY) and Docebo (NASDAQ:DCBO) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.
Expensify currently has a consensus target price of $4.00, suggesting a potential upside of 59.05%. Docebo has a consensus target price of $44.13, suggesting a potential upside of 49.93%. Given Expensify's higher possible upside, analysts clearly believe Expensify is more favorable than Docebo.
In the previous week, Expensify had 5 more articles in the media than Docebo. MarketBeat recorded 8 mentions for Expensify and 3 mentions for Docebo. Docebo's average media sentiment score of 0.43 beat Expensify's score of 0.36 indicating that Docebo is being referred to more favorably in the news media.
Docebo has a net margin of 10.34% compared to Expensify's net margin of -6.66%. Docebo's return on equity of 55.63% beat Expensify's return on equity.
68.4% of Expensify shares are owned by institutional investors. Comparatively, 53.2% of Docebo shares are owned by institutional investors. 12.3% of Expensify shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Expensify has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. Comparatively, Docebo has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500.
Docebo has higher revenue and earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.
Summary
Docebo beats Expensify on 10 of the 15 factors compared between the two stocks.
Get Expensify News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Expensify Competitors List
Related Companies and Tools
This page (NASDAQ:EXFY) was last updated on 7/4/2025 by MarketBeat.com Staff
